Hypophosphatemia after Start of Medical Nutrition Therapy Indicates Early Refeeding Syndrome and Increased Electrolyte Requirements in Critically Ill Patients but Has No Impact on Short-Term Survival
Nutrients · 22.03.2024 · 16 (7) · 922
DOI: 10.3390/nu16070922 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Nutrients, online erschienen am 22.03.2024. Verfasst von Mathias Schneeweiss-Gleixner und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine III, Clinical Division of Gastroenterology and Hepatology, Intensive Care Unit 13H1, Medical University of Vienna, 1090 Vienna…. Hauptthemen laut MEDLINE: Hypophosphatemia, Nutrition Therapy, Refeeding Syndrome. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Refeeding syndrome (RFS) is a potentially life-threatening complication in malnourished (critically ill) patients. The presence of various accepted RFS definitions and the inclusion of heterogeneous patient populations in the literature has led to discrepancies in reported incidence rates in patients requiring treatment at an intensive care unit (ICU). We conducted a prospective observational study from 2010 to 2013 to assess the RFS incidence and clinical characteristics among medical ICU patients at a large tertiary center. RFS was defined as a decrease of more than 0.16 mmol/L serum phosphate to values below 0.65 mmol/L within seven days after the start of medical nutrition therapy or pre-existing serum phosphate levels below 0.65 mmol/L. Overall, 195 medical patients admitted to the ICU were included. RFS was recorded in 92 patients (47.18%). The presence of RFS indicated significantly altered phosphate and potassium levels and was accompanied by significantly more electrolyte substitutions (phosphate, potassium, and magnesium). No differences in fluid balance, energy delivery, and insulin requirements were detected. The presence of RFS had no impact on ICU length of stay and ICU mortality. Screening for RFS using simple diagnostic criteria based on serum phosphate levels identified critically ill patients with an increased demand for electrolyte substitutions. Therefore, stringent monitoring of electrolyte levels is indicated to prevent life-threatening complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine III, Clinical Division of Gastroenterology and Hepatology, Intensive Care Unit 13H1, Medical University of Vienna, 1090 Vienna, Austria.
ORCID-Profile: Mathias Schneeweiss-Gleixner
Zitieren
APA
Schneeweiss-Gleixner, M., Haselwanter, P., Schneeweiss, B., Zauner, C., & Riedl-Wewalka, M. (2024). Hypophosphatemia after Start of Medical Nutrition Therapy Indicates Early Refeeding Syndrome and Increased Electrolyte Requirements in Critically Ill Patients but Has No Impact on Short-Term Survival. Nutrients, 16(7), 922. https://doi.org/10.3390/nu16070922
Vancouver
Schneeweiss-Gleixner M, Haselwanter P, Schneeweiss B, Zauner C, Riedl-Wewalka M. Hypophosphatemia after Start of Medical Nutrition Therapy Indicates Early Refeeding Syndrome and Increased Electrolyte Requirements in Critically Ill Patients but Has No Impact on Short-Term Survival. Nutrients. 2024;16(7):922. doi:10.3390/nu16070922
BibTeX
@article{SchneeweissGleixner2024,
author = {Schneeweiss-Gleixner, Mathias and Haselwanter, Patrick and Schneeweiss, Bruno and Zauner, Christian and Riedl-Wewalka, Marlene},
title = {Hypophosphatemia after Start of Medical Nutrition Therapy Indicates Early Refeeding Syndrome and Increased Electrolyte Requirements in Critically Ill Patients but Has No Impact on Short-Term Survival},
journal = {Nutrients},
year = {2024},
volume = {16},
number = {7},
pages = {922},
doi = {10.3390/nu16070922}
}
EUVIMED